Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Swiss - Delayed Quote CHF

CPH Group AG (CPHN.SW)

Compare
63.80
-3.60
(-5.34%)
At close: April 4 at 5:30:34 PM GMT+2
Loading Chart for CPHN.SW
  • Previous Close 67.40
  • Open 67.20
  • Bid 62.00 x --
  • Ask 65.00 x --
  • Day's Range 63.40 - 67.20
  • 52 Week Range 62.00 - 93.20
  • Volume 2,360
  • Avg. Volume 2,394
  • Market Cap (intraday) 382.404M
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) 81.79
  • EPS (TTM) 0.78
  • Earnings Date Feb 25, 2025
  • Forward Dividend & Yield 2.00 (3.13%)
  • Ex-Dividend Date Mar 20, 2025
  • 1y Target Est 92.53

CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. The Chemistry division develops, manufactures, and distributes a range of molecular sieves, special zeolites, chromatography gels, and deuterated solvents under the Zeochem brand name. The Packaging division provides a range of PVC mono films and coated PVdC barrier films for use in the pharmaceutical industry under the Perlen Packaging brand name. The company also manufactures newsprint and magazine paper products. CPH Group AG was founded in 1818 and is based in Root, Switzerland.

cph.ch

959

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CPHN.SW

View More

Performance Overview: CPHN.SW

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

CPHN.SW
10.66%
MSCI WORLD (^990100-USD-STRD)
11.07%

1-Year Return

CPHN.SW
25.99%
MSCI WORLD (^990100-USD-STRD)
3.01%

3-Year Return

CPHN.SW
11.45%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

CPHN.SW
12.22%
MSCI WORLD (^990100-USD-STRD)
86.12%

Compare To: CPHN.SW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CPHN.SW

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    382.40M

  • Enterprise Value

    369.74M

  • Trailing P/E

    81.79

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.85

  • Price/Book (mrq)

    1.83

  • Enterprise Value/Revenue

    0.83

  • Enterprise Value/EBITDA

    11.97

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.04%

  • Return on Assets (ttm)

    4.03%

  • Return on Equity (ttm)

    1.44%

  • Revenue (ttm)

    447.86M

  • Net Income Avi to Common (ttm)

    4.65M

  • Diluted EPS (ttm)

    0.78

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    31.6M

  • Total Debt/Equity (mrq)

    9.04%

  • Levered Free Cash Flow (ttm)

    31.38M

Research Analysis: CPHN.SW

View More

Company Insights: CPHN.SW

Research Reports: CPHN.SW

View More

People Also Watch